Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males
The DOI matches its Crossref record.
Abstract
Colao A, De Rosa M, Sarnacchiaro F, Di Sarno A, Landi ML, Iervolino E, Zarrilli S, Merola B, Lombardi G. Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol 1996;135:548–52. ISSN 0804–4643 The aim of this study was to evaluate the effects of a chronic treatment with the non-ergot-derived dopamine agonist quinagolide (CV 205-502) on sexual and gonadal function in hyperprolactinemic males. Thirteen males with macroprolactinoma and one with microprolactinoma were treated with CV 205-502 at the dose of 0.15–0.6 mg/day for 6–24 months. Baseline prolactin (PRL) was 464 ± 75.7 μg/l. All the patients suffered from libido impairment, five of reduced sexual potency, six had infertility and in four bilateral induced galactorrhea was shown. The semen analysis revealed a severe oligoasthenospermia with reduced sperm count, motility and forward progression, with an abnormal morphology and decreased viability. A significant reduction of serum PRL levels (nadir PRL = 12.3 ± 5.4 μg/l) was obtained during the treatment. Normalization of prolactinemia was reached in 13 of the 14 patients after 3 months. After 1 year, a significant improvement of sperm parameters, in terms of increase of number (from 5600 ± 111 to 20 564 ± 587 mm 3), motility at 1 h (from 24.8 ± 0.1 to 52.6 ± 0.5%), forward progression (from 24 ± 1.4 to 62.3 ± 2.9%) and normal morphology (from 53.8 ± 2.5 to 62.2 ± 2.4%), was recorded. In addition, a significant increase of serum follicle-stimulating hormone (from 5.3 ± 0.6 to 7.8 ± 0.4 U/l), luteinizing hormone (from 4.4 ± 0.5 to 7.7 ± 0.4 U/l) and testosterone (from 3.4 ± 0.4 to 4.7 ± 0.2 μg/l) was recorded. A significant increase of luteinizing hormone (9.4 ± 0.7 U/l) and testosterone (5.2 ± 0.4 μg/l), as well as a further improvement of sperm parameters, was found after 2 years of therapy. Sellar computed tomography and/or magnetic resonance showed a considerable shrinkage (⩾ 30%) of tumoral mass in 8 out of 13 patients with macroprolacinoma. Side effects were recorded in only one patient. In conclusion, the treatment with CV 205-502 normalizing PRL levels improves gonadal and sexual function and fertility in males with prolactinoma, providing good tolerability and excellent patient compliance to medical treatment. This result demonstrates that the impairment of gonadal function in hyperprolactinemic patients is a functional modification. Annamaria Colao, Department of Molecular and Clinical Endocrinology and Oncology, "Federico II" University, via S. Pansini 5, 80131 Naples, Italy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Self-citationColao, A., Sarno, A., Cappabianca, P., Briganti, F., Pivonello, R., Somma, C., Faggiano, A., Biondi, B., & Lombardi, G. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480325 · Cited by 267
Self-citationColao, A., Vitale, G., Cappabianca, P., Briganti, F., Ciccarelli, A., De Rosa, M., Zarrilli, S., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030979 · Cited by 256
Self-citationBone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males
Di Somma, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.807 · Cited by 117
De Rosa, M., Ciccarelli, A., Zarrilli, S., Guerra, E., Gaccione, M., Di Sarno, A., Lombardi, G., & Colao, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02461.x · Cited by 76
Self-citation
Metadata
- Authors
- Colao, A., De Rosa, M., Sarnacchiaro, F., Di Sarno, A., Landi, M. L., Iervolino, E., Zarrilli, S., Merola, B., & Lombardi, G.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-11
- Volume
- 135
- Issue
- 5
- Pages
- 548-552
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2120096954
- Cited by
- 45
- References
- 0
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. https://app.cochat.ai/papers/10.1530/eje.0.1350548
- The paper
- Colao, A., De Rosa, M., Sarnacchiaro, F., Di Sarno, A., Landi, M. L., Iervolino, E., Zarrilli, S., Merola, B., & Lombardi, G. (1996). Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1350548
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.